VEGFA and neoplasm: There are some evidences of tumour-suppresors that inhibit epithelial mesenchymal transition (EMT), such as AIP1, which, working through the inhibition of VEGF-dependent signaling in the tumour niche, limit tumour growth and metastasis [37].